Five years lasting of biological targeted therapy in pulmonary adenocarcinoma patient

Abstract

Authors presented a case report of patients suffered from pulmonary adenocarcinoma. After resection, metastatic have spread occured.

Five years lasting revission of disease on gefitinib therapy was actimed. Nevertheless, patient has got subsequently bladster cancer and the cause of his death was small cell lung cancer.

Keywords

• pulmonary adenocarcinoma
• bove metastases
• gefitinib
• bladder cancer
• small cell lung cancer